Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
- 1 September 2004
- Vol. 22 (27-28) , 3722-3726
- https://doi.org/10.1016/j.vaccine.2004.03.027
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Origin and Evolution of Japanese Encephalitis Virus in Southeast AsiaJournal of Virology, 2003
- Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infectionsVaccine, 2002
- Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent.The American Journal of Tropical Medicine and Hygiene, 2001
- Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccinesVaccine, 2000
- Phylogenetic analysis suggests only one serotype of Japanese encephalitis virusVaccine, 2000
- New initiatives for the control of Japanese encephalitis by vaccination:Vaccine, 2000
- Antigenic and Genetic Variations among Japanese Encephalitis Virus Strains Belonging to Genotype 1Microbiology and Immunology, 1997
- Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasivenessJournal of General Virology, 1996
- Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responsesVaccine, 1993
- Protection against Japanese Encephalitis by Inactivated VaccinesNew England Journal of Medicine, 1988